Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ophthotech Corp (NASDAQ:OPHT)

64.24
Delayed Data
As of Jul 29
 -0.79 / -1.21%
Today’s Change
35.72
Today|||52-Week Range
80.00
-18.20%
Year-to-Date
These 3 Biotechs Have Automatic Demand
Jul 23 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close65.03
Today’s open64.94
Day’s range63.36 - 65.02
Volume586,952
Average volume (3 months)479,072
Market cap$2.3B
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-3.73%
Earnings growth (this year)-60.62%
Earnings growth (next 5 years)--
Revenue growth (last year)+24.83%
P/E ratioNM
Price/Sales52.72
Price/Book38.15

Competitors

 Today’s
change
Today’s
% change
BLUEbluebird bio Inc+1.09+1.94%
NKTRNektar Therapeutics+1.19+7.39%
NVAXNovavax Inc-0.06-0.81%
RDUSRadius Health Inc+1.32+2.88%
Data as of 3:59pm ET, 07/29/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$1.08
Annual revenue (last year)$51.5M
Annual profit (last year)-$105.7M
Net profit margin-205.26%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
David R. Guyer
President &
Vice Chairman
Samir Chandrakant Patel
Corporate headquarters
New York, New York

Forecasts

Partner Offers

Search for Jobs